1. Home
  2. TFX vs BLCO Comparison

TFX vs BLCO Comparison

Compare TFX & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teleflex Incorporated

TFX

Teleflex Incorporated

HOLD

Current Price

$109.97

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$17.27

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFX
BLCO
Founded
1943
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
6.0B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
TFX
BLCO
Price
$109.97
$17.27
Analyst Decision
Hold
Hold
Analyst Count
10
14
Target Price
$139.88
$17.31
AVG Volume (30 Days)
732.0K
369.2K
Earning Date
02-26-2026
02-18-2026
Dividend Yield
1.24%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,189,988,000.00
$4,976,000,000.00
Revenue This Year
$9.90
$8.06
Revenue Next Year
$10.51
$5.79
P/E Ratio
N/A
N/A
Revenue Growth
5.42
6.23
52 Week Low
$102.58
$10.45
52 Week High
$185.94
$18.34

Technical Indicators

Market Signals
Indicator
TFX
BLCO
Relative Strength Index (RSI) 33.05 57.58
Support Level $108.39 $16.22
Resistance Level $127.49 $17.55
Average True Range (ATR) 3.05 0.35
MACD -1.50 -0.02
Stochastic Oscillator 10.79 74.44

Price Performance

Historical Comparison
TFX
BLCO

About TFX Teleflex Incorporated

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: